Resveratrol improves delayed r‐tPA treatment outcome by reducing MMP s

J Chen, Q Bai, Z Zhao, H Sui… - Acta Neurologica …, 2016 - Wiley Online Library
Objectives Although recombinant tissue plasminogen activator (r‐tPA) is currently the most
effective treatment for brain ischemic stroke, the 3‐h narrow therapeutic windows severely …
被引用次数：61 相关文章

Resveratrol improves delayed r‐tPA treatment outcome by reducing MMP s

J Chen, Q Bai, Z Zhao, H Sui, X Xie - Acta Neurologica Scandinavica, 2016 - infona.pl
Objectives Although recombinant tissue plasminogen activator (r‐tPA) is currently the most
effective treatment for brain ischemic stroke, the 3‐h narrow therapeutic windows severely …

Resveratrol improves delayed r-tPA treatment outcome by reducing MMPs.

J Chen, Q Bai, Z Zhao, H Sui, X Xie - Acta Neurologica …, 2016 - cabdirect.org
Objectives-Although recombinant tissue plasminogen activator (r-tPA) is currently the most
effective treatment for brain ischemic stroke, the 3-h narrow therapeutic windows severely …

Resveratrol improves delayed r-tPA treatment outcome by reducing MMPs

J Chen, Q Bai, Z Zhao, H Sui, X Xie - 2016 - pubmed.ncbi.nlm.nih.gov
Objectives Although recombinant tissue plasminogen activator (r-tPA) is currently the most
effective treatment for brain ischemic stroke, the 3-h narrow therapeutic windows severely …

Resveratrol improves delayed r-tPA treatment outcome by reducing MMPs.

J Chen, Q Bai, Z Zhao, H Sui, X Xie - Acta Neurologica …, 2015 - europepmc.org
Objectives Although recombinant tissue plasminogen activator (r-tPA) is currently the most
effective treatment for brain ischemic stroke, the 3-h narrow therapeutic windows severely …

Resveratrol improves delayed r-tPA treatment outcome by reducing MMPs.

J Chen, Q Bai, Z Zhao, H Sui… - Acta Neurologica …, 2016 - search.ebscohost.com
Objectives Although recombinant tissue plasminogen activator (r-tPA) is currently the most
effective treatment for brain ischemic stroke, the 3-h narrow therapeutic windows severely …

Resveratrol improves delayed r-tPA treatment outcome by reducing MMPs.

J Chen, Q Bai, Z Zhao, H Sui, X Xie - 2016 - cabidigitallibrary.org
Objectives-Although recombinant tissue plasminogen activator (r-tPA) is currently the most
effective treatment for brain ischemic stroke, the 3-h narrow therapeutic windows severely …